7 authorised products containing Aprepitant, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Aprepitant Accord 125 mg hard capsules PA2315/148/002 |
Aprepitant | Accord Healthcare Ireland Ltd. | Marketed |
| Aprepitant Accord 125 mg/80 mg hard capsules PA2315/148/003 |
Aprepitant, Aprepitant | Accord Healthcare Ireland Ltd. | Marketed |
| Aprepitant Accord 80 mg hard capsules PA2315/148/001 |
Aprepitant | Accord Healthcare Ireland Ltd. | Marketed |
| EMEND 125 mg hard capsules EU/1/03/262/004-005 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| EMEND 125 mg hard capsules EMEND 80 mg hard capsules EU/1/03/262/006 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| Emend 125 mg powder for oral suspension EU/1/03/262/011 |
Aprepitant | Merck Sharp & Dohme BV, | — |
| EMEND 80 mg hard capsules EU/1/03/262/001-003 |
Aprepitant | Merck Sharp & Dohme BV, | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.